drugset / Trial / NCT06630117
A Study of V330 in Healthy Younger (18 to 49 Years Inclusive) and Healthy Older (60 to 79 Years Inclusive) Participants (V330-001)
RandomizedSequentialDouble-blindBasic science
Summary
The goal of this study is to learn whether a new vaccine, V330, is safe and learn how well the body's immune system responds by making antibodies after receiving V330.
Timeline
- Start
- 2024-03-01
- Primary completion
- 2025-10-17
- Completion
- 2025-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | V330 | Vaccine | — | Intramuscular |
Indications
No indication recorded.